Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Breast Neoplasms 75Neoplasms 15Neoplasm Metastasis 9Advanced Breast Cancer 5Neoplasms by Site 3Breast Diseases 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Patient Compliance 2Ovarian Neoplasms 2Endometrial Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Skin Diseases 1Recurrence 1Quality of Life 1Osteoporosis 1Multiple Endocrine Neoplasia Type 1 1Low Grade Serous Ovarian Cancer 1Lethal Congenital Contracture Syndrome 2 1Joint Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1Bone Density 1Arthralgia 1Advanced Metastatic Breast Cancer 1

Interventions

Carboplatin 369Pemetrexed 310pembrolizumab 303Cisplatin 244Paclitaxel 230Docetaxel 199Gemcitabine 130Nivolumab 121Erlotinib Hydrochloride 114Bevacizumab 85osimertinib 78atezolizumab 65durvalumab 58Cetuximab 57130-nm albumin-bound paclitaxel 56Gefitinib 52Ipilimumab 46Afatinib 38Drug Therapy 33Cyclophosphamide 30Crizotinib 30Albumin-Bound Paclitaxel 30Vinorelbine 28tislelizumab 26cemiplimab 26avelumab 23icotinib 22Radiotherapy 22capmatinib 21Oxaliplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Non-Small-Cell Lung × Anastrozole × Clear all
NCT02779751 2026-01-26

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

Eli Lilly and Company

Phase 1 Active not recruiting
100 enrolled
BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡